Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NaPi-2a blockers(solute carrier family 34 member 1 blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H14ClF3N4O2 |
InChIKeyATFQBBCQZKVZJN-QMMMGPOBSA-N |
CAS Registry2227425-05-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Preclinical | US | 12 Apr 2018 |